Reducing manual touchpoints is an important part of supporting more consistent and scalable manufacturing processes.

Study found that that breath samples from children with asthma could predict intestinal abundance of a bacterium, Eubacterium siraeum, linked to the condition.

MYC‑driven tumors silence innate immune alarms by clearing R‑loop–derived signals, exposing a new therapeutic angle for targeting MYC without broad inhibition.

A team at Johns Hopkins Medicine has focused their work on myelin development using oligodendrocytes to help study conditions like MS.

Chai Discovery, Noetik, and Boltz have entered multi-year pharma partnerships focused on models, not molecules, hinting at AI’s “infrastructure moment.” ...

The new investment in the Holly Springs facility is on top of the initial commitment in May 2025, and groundbreaking in August 2025.

The so-called magneto-sensitive fluorescent proteins or MFPs, overcome key limitations of previous biological candidates for quantum sensors.

GlaxoSmithKline (GSK) has agreed to acquire Rapt Therapeutics for $2.2 billion, the companies said today, in a deal intended to bolster the buyer’s pipeline with Rapt’s ozureprubart (RPT904), a ...

The discovery fundamentally changes the understanding of a structure in the avian eye that has been misinterpreted for centuries.

According to the data, when microglia activity in the brain was suppressed, baby mice were better able to recall fearful experiences.

Danish researchers have created new cell lines that need a less tailored feeding schedule and produce fewer waste products.

Manufacturing differences between ranibizumab and aflibercept biosimilars might shape pricing, uptake, and patient access globally.